FDA chief Stephen Hahn said the COVID-19 pandemic has shed light on the need for increased use of real-world evidence to help regulators make decisions in real time, and he asked Congress to provide more support for advancing generation of RWE. “We have an access-to-information issue,” Hahn told House lawmakers Tuesday (June 23). “We have learned that we need to collect real-world evidence in real time during an emergency just like a doctor would do during an emergency, to inform...